CLDX
NASDAQStockCelldex Therapeutics, Inc.
$29.72-1.51 (-4.84%)
52-Week Range
$15.13
$31.23
Key Stats
Market Cap
2.0B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.26
Volume
351.9K
Avg Volume
1.2M
Performance
1M
+21.46%
3M
+10.30%
6M
+21.96%
YTD
+10.63%
1Y
+48.36%
3Y
-32.12%
5Y
+19.57%
Price Chart
ETF Exposure
CLDX is held by 77 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SURI | Simplify Propel Opportunities ETF | 3.12% |
| SBIO | ALPS Medical Breakthroughs ETF | 1.33% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.84% |
| XBI | State Street SPDR S&P Biotech ETF | 0.75% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.31% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.16% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.15% |
| FSMO | Fidelity Small-Mid Cap Opportunities ETF | 0.14% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.14% |
| IWN | iShares Russell 2000 Value ETF | 0.14% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.14% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.13% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.12% |
| PWS | Pacer WealthShield ETF | 0.12% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.11% |
| DFAS | Dimensional - US Small Cap ETF | 0.10% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.09% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.07% |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.07% |
| IWM | iShares Russell 2000 ETF | 0.07% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.07% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.06% |
| RSSL | Global X - Russell 2000 ETF | 0.05% |
| VTWO | Vanguard Russell 2000 ETF | 0.05% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.05% |
| UWM | ProShares - Ultra Russell2000 | 0.05% |
| URTY | ProShares - UltraPro Russell2000 | 0.04% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.03% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.03% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.03% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.03% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.03% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.03% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.02% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.02% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.02% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.02% |
| VHT | Vanguard Health Care ETF | 0.02% |
| VXF | Vanguard Extended Market ETF | 0.02% |
| WSML | iShares MSCI World Small-Cap ETF | 0.02% |
| DXUV | Dimensional - US Vector Equity ETF | 0.02% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.02% |
| SMMD | iShares Russell 2500 ETF | 0.02% |
| HDG | ProShares - Hedge Replication ETF | 0.01% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.01% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.01% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.01% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.01% |
Page 1 of 2Next
About CLDX ETF Exposure
Celldex Therapeutics, Inc. (CLDX) is held by 77 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.0B, CLDX is a widely held institutional stock. The stock currently trades at $29.72. Investors can gain exposure to CLDX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CLDX, sorted by portfolio weight.